Pacific Biosciences is reducing both headcount and spending across its DNA sequencing business, in the face of escalating ...

PacBio reaffirms 2025 revenue outlook and unveils cost-cutting measures as Vega system demand grows and Revio usage meets ...

Pacific Biosciences of California (also known as PacBio) is pioneering long-read sequencing technology, which uses longer DNA segments to map the whole genome. Long-read sequencing can uncover ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & ...

The research, conducted by experts from PacBio, GeneDx, and a global genomics consortium, utilizes an informatics tool called Paraphase in combination with HiFi long-read sequencing to improve the ...

MENLO PARK, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in ...

PacBio’s earnings surpassed the Zacks Consensus Estimate in two of the trailing four quarters and met twice, delivering an average surprise of 7.9%. Sequencing Technologies Strengthen Market ...

PacBio MENLO PARK, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation ...

Pioneering what scientists call "HiFi long-read sequencing," recognized as Nature Methods' method of the year for 2022, Pacific Biosciences (NASDAQ:PACB) develops advanced DNA sequencing systems that ...